drugset / Trial / NCT07040969
Spirulina-Derived Product Alleviates Oral Mucositis in Patients Undergoing Radiotherapy for Malignant Head and Neck Tumors
RandomizedParallel-groupQuadruple-blindPrevention
Summary
To evaluate the efficacy and safety of Spirulina-Derived Product for prevention and treatment of oral mucositis in patients undergoing radiotherapy for malignant head and neck tumors.
Timeline
- Start
- 2025-06-27
- Primary completion
- 2026-01-15
- Completion
- 2026-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | spirulina-derived exosomes | Unknown | — | Oral |